FDA Brief

Company record

CytoDyn, Inc.

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about CytoDyn, Inc..

Warning letters

  1. CytoDyn, Inc.

    FDA warns CytoDyn over video promoting unapproved leronlimab as safe and effective for COVID-19.

    High risk